Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001404995 | SCV001606905 | likely benign | Brugada syndrome 8 | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002442786 | SCV002733433 | uncertain significance | Cardiovascular phenotype | 2022-02-10 | criteria provided, single submitter | clinical testing | The p.A756T variant (also known as c.2266G>A), located in coding exon 8 of the HCN4 gene, results from a G to A substitution at nucleotide position 2266. The alanine at codon 756 is replaced by threonine, an amino acid with similar properties. This variant was reported in an individual with arrhythmogenic right ventricular cardiomyopathy (ARVC); however, clinical details were limited (Kolokotronis K et al. J Clin Med, 2020 Jul;9:[Epub ahead of print]). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV003324803 | SCV004030990 | uncertain significance | not provided | 2023-08-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32659924) |
Institute of Human Genetics, |
RCV001842016 | SCV000992453 | uncertain significance | Cardiac arrhythmia | no assertion criteria provided | clinical testing |